-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cardiovascular disease (CVD) is the leading comorbidity of diabetes
Vascular Diabetes Diabetes is associated with worse outcomes after coronary revascularization and was identified as an independent predictor of adverse events in CVD patients
Myocardial infarction , PCI resulted in a higher 5-year rate of MACCE (major adverse cardiovascular and cerebrovascular events: a composite of all-cause death, cerebrovascular accident, MI or repeat revascularization) rate compared with CABG due to a high rate of repeated revascularization
The SYNTAXES study evaluated 10-year survival in 1800 patients with three-vessel disease (3VD) and/or left main coronary artery disease (LMCAD) who were randomized to PCI or CABG in the SYNTAX trial
Among diabetic patients (n = 452), PCI was associated with a higher risk of death at 5 years compared with CABG [19.
Among diabetic patients (n = 452), PCI was associated with a higher risk of death at 5 years compared with CABG [19.
In insulin-treated patients (n = 182), all-cause death after 10 years was numerically higher than in PCI (47.
Effects of PCI and CABG on 10-year all-cause mortality in 3VD/LMCAD patients with drug-treated diabetes and insulin-treated diabetes
Effects of PCI and CABG on 10-year all-cause mortality in 3VD/LMCAD patients with drug-treated diabetes and insulin-treated diabetes
In conclusion, in patients with 3VD and/or LMCAD, regardless of the presence of diabetes, PCI and CABG were similar in the treatment of all-cause mortality within 10 years
references:
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease , European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 56–67, https://doi.
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery diseaseLeave
a message here